A. Zanini (Gavirate, Italy), A. Olin (Gothenburg, Sweden), G. Hillas (Ilioupoli, Greece), C. Bucca (Turin, Italy)
LATE-BREAKING ABSTRACT: Association of free radical formation and respiratory functional parameters in patients with chronic obstructive pulmonary disease: an Electron Paramagnetic Resonance study
V. Ilieva-Fartunova, G. Nikolova, D. Ivanova, A. Zheleva, V. Gadzheva, V. Tsoneva, D. Dimov, A. Koychev (Stara Zagora, Bulgaria)
|   |
LATE-BREAKING ABSTRACT: The Guangzhou COPD exacerbation study: relationship of exacerbations with viral infections and soluble biomarkers
C. McCrae, Y. Zhou, J. Qian, J. Xia, C. Wang, M. van Geest, R. Tang, L. Zheng, C. Liu, A. Nilsson, M. Zhang, Z. Taib, J. Zheng, P. Bruijnzeel, Y. Gu, R. Chen, N. Zhong (Mölndal, Sweden; Guangzhou, Shanghai, China)
| |
Hydrogen sulphide as a biomarker in COPD and asthma
D. Jash, D. Jash (Kolkata, India)
| |
Hydrogen sulfide (H2S) in sputum and serum as a novel biomarker of COPD
J. Saito, A. Mackay, C. Rossios, D. Gibeon, P. Macedo, R. Sinharay, P. Bhavsar, M. Munakata, J. Wedzicha, K. F. Chung (London, United Kingdom; Fukushima, Japan)
| |
A new sensitive panel for in vivo monitoring of mast cell activation in urine samples
J. Bood, J. Kolmert, T. Gülen, I. Delin, C. Wheelock, B. Dahlén, G. Nilsson, S. E. Dahlén (Stockholm, Sweden)
| |
Serum periostin in asthma: A potential biomarker for stratification in severe treatment-resistant asthma
H. Rupani, L. Lau, J. Ono, S. Ohta, C. Barber, S. Elliot, T. Brown, R. Kurukulaaratchy, A. Chauhan, K. Izuhara, P. Howarth (Southampton, Portsmouth, United Kingdom; Kanagawa, Saga, Japan)
| |
Laboratory and clinical parameters in predicting risk of future exacerbations in both non-smoking and smoking COPD patients
A. Tahanovich, A. Kadushkin (Minsk, Belarus)
| |
Chronic obstructive pulmonary disease (COPD) and alterations of hemogram
R. Hasa, H. Hafizi, D. Todri, R. Hasa, E. Tashi, S. Telo (Tirana, Albania)
| |
The relationship between surfactant protein D and respiratory functions in COPD
E. Sen, F. Ciftci, G. Arkan, D. Acar, S. Saryal (Ankara, Turkey)
| |
The lipokine, or palmitoleic acid (16:1), is a biomarker of lung function in chronic obstructive pulmonary disease (COPD)
H. Wada, S. I. Hagiwara, Y. Yamamoto, H. Goto, I. Adcock, H. Takizawa (Tokyo, Tochigi, Japan; London, United Kingdom)
| |
Relationship of circulating soluble urokinase plasminogen activator receptor (suPAR) levels to disease control in asthma and asthmatic pregnancy
I. Ivancsó, G. Toldi, A. Bohács, N. Eszes, V. Müller, J. Rigó Jr., B. Vásárhelyi, G. Losonczy, L. Tamási (Budapest, Hungary)
| |
Serum vitamin D, magnesium and calcium on lung function and QoL in COPD: A cross-sectional study
S. Hashim Ali Hussein, L. P. Nielsen, M. Konow Bogebjerg Dolberg, R. Dahl (Aarhus, Odense, Denmark)
| |
Surfactant protein expression at various COPD Gold stages
S. Seehase, H. Watz, C. Kugler, E. Vollmer, T. Goldmann (Borstel, Grosshansdorf, Germany)
| |
Prevalence of exacerbation in COPD patients with chronic bronchitis and association with elevated serum inflammatory biomarkers
T. Kawamatawong, K. Lueprasitsakul (Bangkok, Thailand)
| |
Fibrinogen and CRP biomarkers in patients with exacerbation of COPD group C and D
M. Ilisie, L. Davidescu, A. Genda, R. Ulmeanu (Oradea, Bucharest, Romania)
| |
Neutrophil/lymphocyte (NLR) ratio in infectious acute exacerbations of COPD (AECOPD)
N. Rovina, E. Dima, S. A. Gennimata, S. Vakali, A. Koutsoukou, N. Koulouris (Athens, Greece)
| |
Laboratory monitoring of neonates' infectious process
L. Gurina (Grodno, Belarus)
| |
Assessment of patients preferences regarding characteristics associated with treatment of chronic obstructive pulmonary disease
E. Bulcun, M. Ekici, A. Ekici (Kirikkale, Turkey)
| |
Higher prevalence and level of IgE, particularly to furry animals, in subjects with asthma in Sweden
S. Sjolander, A. Bjerg, L. Ekerljung, M. Rudengren, M. Berthold, O. Bengtsson-Gref, M. Borres, E. Rönmark, J. Lötvall, B. Lundbäck (Uppsala, Gothenburg, Umeå, Sweden)
| |